Cargando…
Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics
Understanding the role of Tau protein aggregation in the pathogenesis of Alzheimer's disease is critical for the development of new Tau-based therapeutic strategies to slow or prevent dementia. We tested the hypothesis that Tau pathology is associated with functional organization of widespread...
Autores principales: | Kocagoncu, Ece, Quinn, Andrew, Firouzian, Azadeh, Cooper, Elisa, Greve, Andrea, Gunn, Roger, Green, Gary, Woolrich, Mark W., Henson, Richard N., Lovestone, Simon, Rowe, James B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269692/ https://www.ncbi.nlm.nih.gov/pubmed/32280029 http://dx.doi.org/10.1016/j.neurobiolaging.2020.03.009 |
Ejemplares similares
-
Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease
por: Kocagoncu, Ece, et al.
Publicado: (2022) -
Imaging Aβ and tau in early stage Alzheimer’s disease with [(18)F]AV45 and [(18)F]AV1451
por: Firouzian, Azadeh, et al.
Publicado: (2018) -
PET Tau and Amyloid-β Burden in Mild Alzheimer’s Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers
por: Koychev, Ivan, et al.
Publicado: (2017) -
New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol
por: Lanskey, Juliette Helene, et al.
Publicado: (2022) -
Neurophysiological signatures of Alzheimer’s disease and frontotemporal lobar degeneration: pathology versus phenotype
por: Sami, Saber, et al.
Publicado: (2018)